Rasio cepet: Neuronetics, Inc. (STIM)

The daily price action for Neuronetics, Inc. (STIM) illustrated below reflects the dynamics of a company utilizing contract electronics manufacturing and third-party logistics to service US medical centers, with the current metric standing at 1.77. The business mitigates risks through global sales of software and equipment for treating depression. In its maturity stage, Neuronetics, Inc. (STIM) is expanding access to non-invasive TMS therapy as an alternative to medication.

Quick liquidity determines a business's ability to instantaneously settle short-term obligations using its most liquid assets. By analyzing the quick liquidity trajectory, an investor assesses a company's margin of safety excluding inventory. This metric is formed by the ratio of cash and accounts receivable to current liabilities. For Neuronetics, Inc. (STIM), such stability is critical for defending its market niche in high-tech stimulation systems under conditions of strict regulatory control.